Abcam Establishes New Direct Service for Australia and New Zealand
News Aug 12, 2014
Abcam plc announced today it has established a direct service to Australia and New Zealand. The move signifies the importance of this region and Abcam’s focus on providing the best products and services to accelerate the pace of researchers’ scientific discoveries.
The new service enables customers in Australia and New Zealand to order their research tools directly from Abcam rather than through a distributor. These customers will also benefit from direct technical support, and delivery times reduced by up to 50% from order to delivery.
Philippe Cotrel, Commercial Director, Abcam, said: “I’m delighted that we can offer an enhanced service to our customers in Australia and New Zealand. A direct service will enable us to develop closer relationships with our customers, and ensure we are fully meeting their research needs.”
Abcam’s experienced technical and customer support teams and in-house manufacturing facilities provide researchers worldwide with high-performance products that they can trust, such as RabMAb® primaries.
All in a Droplet: Atomic Resolution of ALS Protein ResolvedNews
Researchers have described atom-by-atom changes in a family of proteins linked to amyotrophic lateral sclerosis (ALS), a group of brain disorders known as frontotemporal dementia and degenerative diseases of muscle and bone.READ MORE
Study Reveals How MRSA Infection Compromises Lymphatic FunctionNews
Infections of the skin or other soft tissues with the hard-to-treat MRSA bacteria appear to permanently compromise the lymphatic system, which is crucial to immune system function. Investigators describe how MRSA infection impairs the ability of lymphatic vessels to pump lymphatic fluid to lymph nodes in mouse models, which may contribute to the frequent recurrences of MRSA infection experienced by patients.